BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 30685083)

  • 21. Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
    Donnarumma JFS; Ferreira EVM; Ota-Arakaki J; Kayser C
    Adv Rheumatol; 2019 Jan; 59(1):1. PubMed ID: 30657102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
    Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
    Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.
    Johnson SR; Granton JT
    Eur Respir Rev; 2011 Dec; 20(122):277-86. PubMed ID: 22130821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review.
    Li M; Tian Z; Qian J; Huang C; Zhao J; Wang Q; Song Y; Tian X; Li M; Liu J; Zeng X
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35256456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
    Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
    Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Cansu DÜ; Korkmaz C
    Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients.
    Murata I; Takenaka K; Yoshinoya S; Kikuchi K; Kiuchi T; Tanigawa T; Ito K
    Chest; 1997 Jan; 111(1):36-43. PubMed ID: 8995990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.
    Alayoud A; Qamouss O; Hamzi A; Benyahia M; Oualim Z
    Arab J Nephrol Transplant; 2012 Sep; 5(3):153-7. PubMed ID: 22967254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy.
    Ruiz-Irastorza G; Garmendia M; Villar I; Egurbide MV; Aguirre C
    Autoimmun Rev; 2013 Jan; 12(3):410-5. PubMed ID: 22841984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.
    Dhala A
    Clin Dev Immunol; 2012; 2012():854941. PubMed ID: 22489252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.
    Assous N; Allanore Y; Batteux F; Meune C; Toulon P; Weill B; Kahan A
    Clin Exp Rheumatol; 2005; 23(2):199-204. PubMed ID: 15895890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA;
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.
    Huang C; Li M; Liu Y; Wang Q; Guo X; Zhao J; Lai J; Tian Z; Zhao Y; Zeng X
    Medicine (Baltimore); 2016 Mar; 95(10):e2761. PubMed ID: 26962774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Anemic Hypoxia and Increased Pulmonary Artery Systolic Pressure in Patients With Systemic Lupus Erythematosus.
    Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1702-11. PubMed ID: 26018410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat.
    Kuzuya K; Tsuji S; Matsushita M; Ohshima S; Saeki Y
    Cureus; 2019 Mar; 11(3):e4327. PubMed ID: 31183306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus.
    Lian F; Chen D; Wang Y; Ye Y; Wang X; Zhan Z; Xu H; Liang L; Yang X
    Rheumatol Int; 2012 Jun; 32(6):1727-31. PubMed ID: 21437686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study.
    Jia E; Geng H; Liu Q; Xiao Y; Zhang Y; Xie J; Zhang L; Qiu X; Zhong L; Xiao M; Zhang J
    Ir J Med Sci; 2019 Aug; 188(3):801-806. PubMed ID: 30460452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population.
    Pan Y; Sun Y; He L
    Int J Rheum Dis; 2022 Jan; 25(1):76-82. PubMed ID: 34796660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model.
    Dai M; Zhang C; Li C; Wang Q; Gao C; Yue R; Yao M; Su Z; Zheng Z
    Arthritis Res Ther; 2023 Aug; 25(1):155. PubMed ID: 37612772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.